At Regulaite, we are at the forefront of AI compliance, specializing in aiding organizations to navigate the complex landscape of ISO 42001 and its intersections with ISO 27001. Our dedication extends to ensuring that AI technologies are both safe for humanity and conducive to innovation. With our focus sharpened on AI Biotech, Pharmaceutical, and Drug Discovery sectors, we are uniquely positioned to address the specific challenges and opportunities these industries face.

Regulating AI is not just a challenge; it is the critical task of our era. We have established the first dedicated AI regulation lab, focusing exclusively on creating safe, reliable, and innovation-friendly regulatory guidelines for AI. Our work with industry-leading firms underscores our commitment and capability in this essential field.

Our approach is both methodical and ambitious. We integrate safety, capability development, and innovation as the core pillars of our technical strategy. This ensures that every advance in AI regulation promotes robust safety measures without stifling technological progress. By achieving this balance, we progress confidently, knowing our guidelines are secure, reliable, and supportive of innovation.

Regulaite is built for focus and efficiency. With no distractions from managerial overhead or extraneous product cycles, our business model is designed to insulate our mission from short-term commercial pressures. This focus ensures that our work on AI regulation remains steady, undeterred, and innovation-centric.

Based in the United States, with strategic partnerships in Austria and Switzerland, Regulaite is well-positioned to attract top-tier technical talent. Our roots in these innovation hubs enable us to collaborate with leading minds in engineering and research, fostering an environment of excellence, breakthrough, and creativity.


Regulaite

Org chart

Teams

Offices

Similar companies